Skip to content

Food and the heart: the benefits of a Nutritional Intervention for people with Heart Failure

Effect of a Nutritional Intervention on clinical, laboratory and quality of life parameters of patients with Heart Failure: 6-month follow-up

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7gs22jk
Enrollment
Unknown
Registered
2025-04-24
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

This is a cohort intervention study conducted with patients with heart failure followed at the multidisciplinary heart failure outpatient clinic of the University Hospital of the Federal University of

Sponsors

Centro de Ciências Biológicas e da Saúde da Universidade Federal de São Carlos
Lead Sponsor
Hospital Universitário da Universidade Federal de São Carlos
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Agreement to participate in the study and signing of the Free and Informed Consent Form - TCLE. Patients diagnosed with Heart Failure - HF. HF with slightly reduced ejection fraction or HF with reduced ejection fraction, with ventricular ejection fraction less than 50%, according to the last echocardiogram performed. Patients over 18 years of age. Both sexes. Patients free of decompensation due to HF for at least 3 months before inclusion in the project

Exclusion criteria

Exclusion criteria: Pregnant women. Breastfeeding women. Patients with limitations in understanding the guidelines: such as the presence of cognitive disorders or difficulties in reading or understanding the booklet

Design outcomes

Primary

MeasureTime frame
Improvements are expected in clinical, nutritional and quality of life parameters, measured through vital signs, anthropometry, indirect calorimetry, questionnaires and biochemical tests. Data collected in the week of the intervention and six months after the intervention

Secondary

MeasureTime frame
It is expected that there will be a reduction in the need for hospitalization, deaths, heart attacks/reinfarctions, angioplasties, revascularizations, strokes, and other cardiovascular events, measured through monthly monitoring

Countries

Brazil

Contacts

Public ContactGustavo Zani

Universidade Federal de São Carlos

gustavozani48@gmail.com+55(19)992720157

Outcome results

None listed

Source: REBEC (via WHO ICTRP)